Screening method for paraquat simulation antibody and application thereof
A technology of mimicking antibodies and paraquat, which is applied in the field of screening of paraquat mimicking antibodies, can solve the problems of cumbersome determination process, high cost, difficulty in antigen synthesis, etc., and achieve the effect of small molecular weight and clear sequence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1 Screening of Paraquat Mimetic Antibody
[0025] 1. In vitro transcription and translation
[0026] (1) E. coli S30 (Escherichia coli S30Extract System) linear template system from Promega Company was used for in vitro transcription and translation. The reaction system is as follows:
[0027]
[0028] (2) Incubate the system at 37°C for 10 min to complete in vitro transcription and translation. The in vitro translation products were immediately added to 4 volumes of WBTH (pre-cooled) containing 0.5% BSA. Then add 2.6μL Mg(Ac)2 solution and place on ice for 1-2min.
[0029] 2. Solid phase affinity screening
[0030] (1) Coating screening wells: Dilute the PQ-BSA coating to 2 μg / mL with sterilized carbonate buffer, add 100 μL to each well of the microplate (treated with DEPC water), and cover The lids treated with DEPC water were coated overnight at 4°C.
[0031] (2) The next day, pour off the coating solution, and wash the closed well with sterilized PB...
Embodiment 2
[0046] Example 2 Functional expression and purification of paraquat mimetic antibody
[0047] 1. Functional expression of paraquat mimic antibody
[0048] 1. Amplification of Lipocalin-PQ gene after screening
[0049] Amplify the screened gene with primers containing EcoRI and Xhol restriction sites redesigned to amplify the Lipocalin-PQ gene with restriction sites. The primer sequence is as follows: Forward primer EXPRESS (introducing EcoRI restriction site dot): 5′CGC GAATT C ATG AAC GTG TAC CAC GAC GGTG3', reverse primer REPRESS (introduce XhoI restriction site): 5'GCC CTC GAG ATT GTT GAC TTT GCA GGC GGCG3'.
[0050] 2. Construction of recombinant Lipocalin-PQ expression plasmid:
[0051] Plasmid pTIG-TRX was digested with EcoRI and XhoI. 1.5% agarose gel electrophoresis, the Lipocalin-PQ fragment purified by EcoRI and XhoI double digestion and the plasmid pTIG-TRX digested by the same digestion were ligated with T4 DNA ligase, and the host strain BL21(DE3) was tran...
Embodiment 3
[0056] Example 3 Functional Identification of Paraquat Mimetic Antibody
[0057] 1. Detection of the binding activity of the mock antibody Lipocalin-PQ
[0058] PQ-BSA coated enzyme-linked wells, and coated with the same concentration of BSA at the same time, diluted the purified mock antibody Lipocalin-PQ four gradients as the primary antibody solution, mouse anti-6×His tag antibody as the secondary antibody, HRP-labeled sheep Anti-mouse was used as the enzyme-labeled secondary antibody, and the binding activity was detected by direct ELISA method. After color development by TMB, the microplate reader measured the absorbance at 450nm and 630nm, and the difference between the two was the absorbance after the reaction. In order to exclude the non-specific adsorption of the simulated antibody to BSA, the value of PQ-BSA minus the value of BSA was used as the absorbance value of the simulated antibody combined with PQ, and the results were as follows image 3 , the binding of Li...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com